DADC
CRDF icon

D.A. Davidson & Co’s Cardiff Oncology CRDF Stock Holding History

D.A. Davidson & Co’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,218
Closed -$116K – 1115
2017
Q3 		$116K Sell
2,218
-291
-12% -$18.2K ﹤0.01% 1055
2017
Q2 		$227K Sell
2,509
-416
-14% -$26.8K 0.01% 913
2017
Q1 		$242K Hold
2,925
– – 0.01% 859
2016
Q4 		$442K Sell
2,925
-400
-12% -$93.4K 0.01% 691
2016
Q3 		$1.07M Buy
3,325
+445
+15% +$162K 0.03% 447
2016
Q2 		$939K Sell
2,880
-90
-3% -$31K 0.03% 411
2016
Q1 		$994K Buy
2,970
+410
+16% +$139K 0.03% 397
2015
Q4 		$995K Buy
2,560
+952
+59% +$373K 0.03% 400
2015
Q3 		$658K Buy
1,608
+618
+62% +$323K 0.02% 466
2015
Q2 		$723K Sell
990
-1,633
-62% -$1.16M 0.02% 478
2015
Q1 		$1.29M Buy
2,623
+120
+5% +$51.2K 0.04% 350
2014
Q4 		$774K Buy
2,503
+1,030
+70% +$333K 0.03% 470
2014
Q3 		$485K Buy
+1,473
New +$441K 0.02% 602

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

D.A. Davidson & Co's CRDF Position: Q4 2017 in Review

D.A. Davidson & Co sold out of Cardiff Oncology (CRDF) in Q4 2017, closing a stake of 2,218 shares — an estimated $116K sold.

D.A. Davidson & Co first reported a position in CRDF in Q3 2014 and held it in 13 quarters. The position peaked at $1.29M in Q1 2015. 38 funds tracked by Wall St. Rank hold CRDF as of Q4 2017.

  • D.A. Davidson & Co reported no remaining Cardiff Oncology position as of Q4 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,218 Cardiff Oncology shares in Q4 2017, an estimated $116K.
  • D.A. Davidson & Co first reported a position in Cardiff Oncology in Q3 2014 and held it in 13 quarters.
  • D.A. Davidson & Co's Cardiff Oncology position peaked at $1.29M in Q1 2015.
  • 38 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2017.

Based on D.A. Davidson & Co's 13F filing for Q4 2017, filed 8 Feb 2018.